Acquiring Company
QIAGEN N.V
Acquired Company
Genoox
VenloBiotechnologyHealth CareBiotechnologySoftwareHealth CareArtificial IntelligenceGeneticsMachine LearningHealth DiagnosticsBioinformaticsDescription
Qiagen has completed the acquisition of Genoox, an Israeli AI genomics startup, for $80 million. This acquisition enhances Qiagen's Digital Insights portfolio and supports its efforts in advancing clinical genetic testing solutions. Genoox's cloud-based platform, Franklin, is widely used in the industry for analyzing genetic data. The merger aims to improve patient outcomes through innovative technologies.
Quick answer
QIAGEN N.V is acquiring Genoox for $80 million, announced May 12, 2025. QIAGEN N.V is based in Venlo, Limburg, Netherlands.
- How much did QIAGEN N.V pay for Genoox?
- The reported deal value is $80 million.
- What does QIAGEN N.V do?
- QIAGEN N.V. is the leading global provider of Sample to Insight solutions.
- Where are QIAGEN N.V and Genoox based?
- QIAGEN N.V is based in Venlo, Limburg, Netherlands.
- Who are the decision-makers at QIAGEN N.V?
- Fundz holds 1 contact at QIAGEN N.V. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Genetics and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Quanterix to acquire Akoya Biosciences in merger (May 12, 2025)
- Quanterix to acquire Akoya Biosciences shares (April 28, 2025)
- Concentra to acquire Elevation Oncology, shut it down (June 20, 2025)
- Wix acquires Base44 to enhance coding solutions (June 18, 2025)
- XtalPi acquires Liverpool ChiroChem for innovation boost (June 13, 2025)
- Press Ganey Forsta acquires InMoment for CX growth (May 14, 2025)
Who to call at QIAGEN N.V, and when
When QIAGEN N.V changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day QIAGEN N.V raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at QIAGEN N.V, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at QIAGEN N.V. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment QIAGEN N.V makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Genoox?
Genoox was acquired by QIAGEN N.V, based in Venlo. The deal was reported on May 12, 2025. QIAGEN N.V. is the leading global provider of Sample to Insight solutions. QIAGEN N.V is publicly traded (QGEN) and operates in Biotechnology.
When did QIAGEN N.V acquire Genoox?
QIAGEN N.V's acquisition of Genoox was reported on May 12, 2025. Qiagen has completed the acquisition of Genoox, an Israeli AI genomics startup, for $80 million. This acquisition enhances Qiagen's Digital Insights portfolio and supports its efforts in advancing clinical genetic testing solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Genoox do?
Genoox is an AI genomics startup focused on providing software for clinical genetic testing. Founded in 2014, the company developed Franklin, a cloud-based platform that helps laboratories analyze next-generation sequencing data. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.